12
Participants
Start Date
September 30, 2012
Primary Completion Date
September 30, 2012
Study Completion Date
September 30, 2012
PF-05089771
Oral dispersion TS formulation- fasted
PF-05089771
Capsules TS formulation- fasted
Pfizer Investigational Site, Brussels
Lead Sponsor
Pfizer
INDUSTRY